Thyroid

Papers
(The H4-Index of Thyroid is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Geraldo A. de Medeiros-Neto, MD, MACP (June 5, 1935–January 21, 2022)232
Future Meetings179
International Women’s Day: An Occasion for a Tribute to Women Leaders in the American Thyroid Association125
Role of Thyrotropin-Releasing Hormone in Regulating Fibroblast Growth Factor 21 in Mouse Pancreatic β Cells98
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Thyroid93
Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer85
Future Meetings83
Letter to the Editor: ETV6-NTRK2 Fusion Identified in a Patient with Medullary Thyroid Carcinoma79
35th Anniversary of Thyroid—Journal of the American Thyroid Association78
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction69
Discoveries Around the Hypothalamic–Pituitary–Thyroid Axis68
The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005–202067
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro)61
A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal59
Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-Analysis Examining Prevalence, Follow-Up, and Risk of Malignancy59
A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications54
Maternal Exercise Before and During Pregnancy Facilitates Embryonic Myogenesis by Enhancing Thyroid Hormone Signaling52
The Scientific Contributions of Martin Surks, MD, MACP: A Pioneer in Thyroid Hormone Physiology, Subclinical Hypothyroidism, and Endocrine Education48
Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions48
A Conversation with Samuel Refetoff, MD: How Treating One Family Stimulated a Lifelong Series of Major Discoveries in Thyroid Physiology and Disease46
Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy Study44
Regular Call Oral Abstracts43
Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations43
Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants43
Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al.43
A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease43
Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up42
Abstract Author Index41
Letter to the Editor: Remission of Graves' Disease After Initiation of Ocrelizumab in Patients with Multiple Sclerosis40
The Year in Thyroidology: Surgical Science39
Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays39
The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study39
The American Thyroid Association 1923–2023: Honoring Our Past, Embracing Our Future37
Correction to: The Diagnostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/T36
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward36
A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion36
0.79791903495789